Search results
25 sie 2022 · 9. Pulmonary hypertension associated with lung diseases and/or hypoxia (group 3) Pulmonary hypertension is frequently observed in patients with COPD and/or emphysema, ILD, combined pulmonary fibrosis and emphysema (CPFE), and hypoventilation syndromes [52, 165, 707, 708].
Pulmonary arterial hypertension (PAH) is a rapidly progressive disease, ultimately leading to right heart failure and death. Accumulating evidence indicates that intervention early in disease progression results in better outcomes than delaying treatment.
7 kwi 2023 · The definition of pulmonary hypertension (PH) has changed recently based, in part, on contemporary outcome data and to focus on early disease detection. Now, PH includes patients with mean pulmonary artery pressure >20 mm Hg measured by right heart catheterization.
1 wrz 2020 · Abstract. Pulmonary hypertension (PH) is classified into 5 clinical subgroups: pulmonary arterial hypertension (PAH), PH due to left-sided heart disease, PH due to chronic lung disease, chronic thromboembolic PH (CTEPH), and PH with an unclear and/or multifactorial mechanisms.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Nazzareno Galiè1 (ESC Chairperson), Marc Humbert2 (ERS Chairperson), Jean-Luc Vachiery3, Simon Gibbs1, Irene Lang1, Adam Torbicki1, Gérald Simonneau2, Andrew Peacock2, Anton Vonk Noordegraaf2, Maurice Beghetti4, Ardeschir Ghofrani2, Miguel Angel Gomez Sanchez1, Georg Hansmann4, Walter Klepetko3, Patrizio ...
Pulmonary hypertension (PH) is a heterogeneous disease driven most often by pathogenic remodeling of distal pulmonary arterioles or a congestive (functional) vasculopathy resulting from pulmonary venous hypertension.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplant...
